Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: A randomized clinical trial

AIMS: Nasal glucagon (NG) is a nasally‐administered glucagon powder, absorbed through the nasal mucosa, designed for treatment of severe hypoglycaemia. This study evaluated the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of NG in otherwise healthy participants with common colds and after...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Cristina B., Dulude, Helene, Piché, Claude, Rufiange, Marianne, Sadoune, Aziz A., Rampakakis, Emmanouil, Carballo, Dolores, Triest, Myriam, Zhang, Michelle Xiaotian, Zhang, Shuyu, Tafreshi, Maryam, Sicard, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836949/
https://www.ncbi.nlm.nih.gov/pubmed/29053231
http://dx.doi.org/10.1111/dom.13134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836949/
https://www.ncbi.nlm.nih.gov/pubmed/29053231
http://dx.doi.org/10.1111/dom.13134

Ejemplares similares